In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register

OBJECTIVES: To identify baseline disease-related predictors in patients with early inflammatory polyarthritis (IP) for starting subsequent biological therapy and to determine if patients who failed their first non-biological disease-modifying antirheumatic drug (DMARD) within 6 months were more like...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstappen, Suzanne M M, Lunt, Mark, Bunn, Diane K, Scott, David G I, Symmons, Deborah P M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128326/
https://www.ncbi.nlm.nih.gov/pubmed/21551505
http://dx.doi.org/10.1136/ard.2010.148106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128326/
https://www.ncbi.nlm.nih.gov/pubmed/21551505
http://dx.doi.org/10.1136/ard.2010.148106

Ejemplares similares